Elias Notopoulos

Elias, a dynamic corporate attorney at Watson Goepel LLP, thrives on forging deep connections with his clients through a person-first strategy. His adeptness in blending empathy with legal acumen enables him to fully grasp the challenges and opportunities businesses face, guiding them with actionable and strategic advice. Specializing in a wide array of corporate legal matters, Elias's expertise spans mergers and acquisitions, venture capital financings, and intricate corporate restructurings, alongside handling tax-sensitive transactions with finesse.

His knack for tailoring advice to the unique needs of various industries has made him a go-to advisor for businesses. Elias excels in steering companies through complex transactions, advising on corporate governance, drafting commercial agreements, and enhancing risk management strategies. Clients appreciate his practical insights and the ability to decode complex business scenarios with ease.

Raised in Vancouver, Elias finds solace in nature's embrace, balancing his rigorous legal profession with hiking and jet skiing adventures. This equilibrium between professional dedication and personal passion underscores his holistic approach to life and work.

Elias's academic journey is marked by a Master of Laws in Taxation from the University of British Columbia, complemented by a Doctor of Law from Bond University, Australia, and a Bachelor of Business Administration from Simon Fraser University. His legal prowess was officially recognized in British Columbia in 2017.

Elias's portfolio includes facilitating key business transactions across sectors. He has played a pivotal role in the acquisition and divestiture of businesses, adeptly handling both share and asset sales. Notably, he guided a cannabis firm through its strategic exit from the industry, overseeing the sale of its assets and licenses. In the dental sector, he has successfully orchestrated multiple practice acquisitions and subsequent restructuring efforts. Furthermore, Elias has supported several tech, biotech, and life sciences companies through private financing rounds, showcasing his versatility and depth of knowledge in corporate law.